Not investment advice.Read full disclaimer
Continue with finqOS
Side-by-side valuation, growth, and profitability metrics against the closest competitors.
14-day free trial · No credit card required
52W Range
Volume
Mkt Cap
P/E
Div Yield
Publicly traded Aurobindo Pharma Limited (AUROPHARMA.NS) competitors and peer companies. Compare valuation, revenue growth, margins, and profitability against Lupin Limited, Lupin Limited, Laurus Labs Limited, Laurus Labs Limited, Alkem Laboratories Limited, and more.
| Ticker | Company | Market Cap |
|---|---|---|
| LUPIN.BO | Lupin Limited | $1.11T |
| LUPIN.NS | Lupin Limited | $1.11T |
| LAURUSLABS.NS | Laurus Labs Limited | $808.0B |
| LAURUSLABS.BO | Laurus Labs Limited | $805.5B |
| ALKEM.BO | Alkem Laboratories Limited | $661.6B |
| ALKEM.NS | Alkem Laboratories Limited | $656.2B |
| GLENMARK.BO | Glenmark Pharmaceuticals Limited | $620.7B |
| GLENMARK.NS | Glenmark Pharmaceuticals Limited | $620.2B |
| ABBOTINDIA.BO | Abbott India Limited | $538.9B |
| ABBOTINDIA.NS | Abbott India Limited | $538.0B |